ZBH

#614
Zimmer Biomet Holdings, Inc. Common Stock
82.3 4 USD
-0.70%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
82.26
82.83
Jahresspanne
0.83
103.69
Tagesänderung
-0.70%
Monatliche Änderung
+1.90%
6 month change
-15.30%
Jahresänderung
-20.44%
Vorheriger Schlusskurs
82.9 2
Open
82.7 4
Tief
82.2 6
High
82.8 3
Volumen
1 126
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 15.93 B
  • Employee 17 K
  • Founded N/A
  • CEO Ivan Tornos
  • Website www.zimmerbiomet.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKPL53
  • Industry Medizinische Geräte
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
23.42
Preis-Umsatz-Verhältnis
2.21
Dividende je Aktie
0.24
Dividendenrendite in %
1.86

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.

Nachrichten